Pharmacogenomics of Viral Diseases
作者： Shailendra Dwivedi , Suraj Singh Yadav , Manish Kumar Singh , Shailja Shukla , Sanjay Khattri
DOI: 10.1007/978-81-322-1184-6_28
关键词:
摘要: Viral diseases are leading cause of deaths worldwide as WHO report suggests that hepatitis A virus (HAV) infects more than 80 % the population many developing countries. B (HBV) affects an estimated 360 million people, whereas C 123 people worldwide, and last but not least, at current, India has HIV/AIDS approximately 2.4 30 in whole world now it become a reason for 1.8 death globally; thus, millions still struggle their lives.
springer.com
sci-hub.st 参考文章(172)
Purcell Rh, Farci P, Clinical significance of hepatitis C virus genotypes and quasispecies. Seminars in Liver Disease. ,vol. 20, pp. 103- ,(2000)
Ryan Abo, Scott Hebbring, Yuan Ji, Hongjie Zhu, Zhao-Bang Zeng, Anthony Batzler, Gregory D. Jenkins, Joanna Biernacka, Karen Snyder, Maureen Drews, Oliver Fiehn, Brooke Fridley, Daniel Schaid, Naoyuki Kamatani, Yusuke Nakamura, Michiaki Kubo, Taisei Mushiroda, Rima Kaddurah-Daouk, David A. Mrazek, Richard M. Weinshilboum, Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenetics and Genomics. ,vol. 22, pp. 247- 253 ,(2012) , 10.1097/FPC.0B013E32835001C9
Heather J Ribaudo, Catia Marzolini, Todd Hulgan, David B Clifford, Richard B Kim, Edward P Acosta, Roy M Gulick, David W Haas, Camlin Tierney, Grant R Wilkinson, Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. ,vol. 18, pp. 2391- 2400 ,(2004)
Nina Ank, Marie B. Iversen, Christina Bartholdy, Peter Staeheli, Rune Hartmann, Uffe B. Jensen, Frederik Dagnaes-Hansen, Allan R. Thomsen, Zhi Chen, Harald Haugen, Kevin Klucher, Søren R. Paludan, An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. Journal of Immunology. ,vol. 180, pp. 2474- 2485 ,(2008) , 10.4049/JIMMUNOL.180.4.2474
TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329
Richard M. Weinshilboum, Susan L. Sladek, Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. American Journal of Human Genetics. ,vol. 32, pp. 651- 662 ,(1980)
Laurence T. Rimsky, Diane C. Shugars, Thomas J. Matthews, Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides Journal of Virology. ,vol. 72, pp. 986- 993 ,(1998) , 10.1128/JVI.72.2.986-993.1998
Allan. Granoff, Robert G. Webster, Encyclopedia of virology Academic Press. ,(1999)
Daniel R. Kuritzkes, John W. Mellors, Bonaventura Clotet, Lisa M. Demeter, Donna M. Jacobsen, Douglas D. Richman, Clive Loveday, Scott M. Hammer, Victoria A. Johnson, Stefano Vella, Brian Conway, Martin S. Hirsch, Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection ,(2000)
Véronique Zennou, Fabrizio Mammano, Sylvie Paulous, Dominique Mathez, François Clavel, Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors In Vivo Journal of Virology. ,vol. 72, pp. 3300- 3306 ,(1998) , 10.1128/JVI.72.4.3300-3306.1998